Detalhe da pesquisa
1.
Lutetium-177-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer.
N Engl J Med
; 385(12): 1091-1103, 2021 09 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34161051
2.
A plain language summary of the TROPHY-U-01 study: sacituzumab govitecan use in people with locally advanced or metastatic urothelial cancer.
Future Oncol
; 2024 Apr 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38682560
3.
Health-related quality of life and pain outcomes with [177Lu]Lu-PSMA-617 plus standard of care versus standard of care in patients with metastatic castration-resistant prostate cancer (VISION): a multicentre, open-label, randomised, phase 3 trial.
Lancet Oncol
; 24(6): 597-610, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37269841
4.
Response to RL-225Ac in prostate cancer: Effect of prior treatment with RL-177Lu: A systematic review of the literature.
Prostate
; 83(10): 901-911, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36960580
5.
Randomized phase II trial of MRI-guided salvage radiotherapy for prostate cancer in 4 weeks versus 2 weeks (SHORTER).
BMC Cancer
; 23(1): 781, 2023 Aug 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37608258
6.
Efficacy and safety of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma: long-term follow-up of a phase 2 study.
Lancet Oncol
; 23(2): 248-258, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35030333
7.
Pilot study of the diagnostic utility of 89 Zr-df-IAB2M and 68 Ga-PSMA-11 PET imaging and multiparametric MRI in localized prostate cancer.
Prostate
; 82(4): 483-492, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34985786
8.
Serial ctDNA analysis predicts clinical progression in patients with advanced urothelial carcinoma.
Br J Cancer
; 126(3): 430-439, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35046520
9.
Erdafitinib in Locally Advanced or Metastatic Urothelial Carcinoma.
N Engl J Med
; 381(4): 338-348, 2019 07 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-31340094
10.
Mechanisms of Ischemic Stroke in Patients with Cancer: A Prospective Study.
Ann Neurol
; 90(1): 159-169, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34029423
11.
Adherence to Guideline-Recommended Cancer Screening in Stroke Survivors: A Nationwide Analysis.
J Stroke Cerebrovasc Dis
; 31(3): 106297, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35032754
12.
Imaging expression of prostate-specific membrane antigen and response to PSMA-targeted ß-emitting radionuclide therapies in metastatic castration-resistant prostate cancer.
Prostate
; 81(5): 279-285, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33465252
13.
Impact of Late Dosing on Testosterone Suppression with 2 Different Leuprolide Acetate Formulations: In Situ Gel and Microsphere. An Analysis of United States Clinical Data.
J Urol
; 205(2): 554-560, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33090917
14.
Arterial thromboembolic events preceding the diagnosis of cancer in older persons.
Blood
; 133(8): 781-789, 2019 02 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-30578253
15.
A simple strategy to reduce the salivary gland and kidney uptake of PSMA-targeting small molecule radiopharmaceuticals.
Eur J Nucl Med Mol Imaging
; 48(8): 2642-2651, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33495926
16.
Prostate-Specific Membrane Antigen (PSMA)-Targeted Radionuclide Therapies for Prostate Cancer.
Curr Oncol Rep
; 23(5): 59, 2021 03 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-33778927
17.
CD8+ T Cells Impact Rising PSA in Biochemically Relapsed Cancer Patients Using Immunotherapy Targeting Tumor-Associated Antigens.
Mol Ther
; 28(5): 1238-1250, 2020 05 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32208168
18.
Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): overall survival and updated results of a randomised, double-blind, phase 3 trial.
Lancet Oncol
; 21(1): 105-120, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31753727
19.
Meeting report from the Prostate Cancer Foundation PSMA theranostics state of the science meeting.
Prostate
; 80(15): 1273-1296, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32865839
20.
PSMA ADC monotherapy in patients with progressive metastatic castration-resistant prostate cancer following abiraterone and/or enzalutamide: Efficacy and safety in open-label single-arm phase 2 study.
Prostate
; 80(1): 99-108, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31742767